Tag: Biosana
Svas Biosana, 9 month revenues rise to 85.9 million euros
(Finance) – Svas Biosanaa company listed on Euronext Growth Milan and active in the production of medical devices for healthcare facilities, has closed i first nine months of 2024 with…
Svas Biosana announces bond issue for 6 million euros
(Finance) – The Board of Directors of Svas Biosanaa leading operator in the healthcare sector listed on Euronext Growth Milan, has approved the issuance of a non-convertible and non-subordinated bond…
Svas Biosana, revenues up to 58.2 million euros in the first half
(Telestock) – Swas Biosanaa company listed on Euronext Growth Milan and active in the production of medical devices for healthcare facilities, has closed the first semester of 2024 with consolidated…
Svas Biosana, 2023 profit rises to 5.1 million. Dividend of 0.30 euros
(Finance) – Svas Biosanaa company listed on Euronext Growth Milan and active in the production of medical devices for healthcare facilities, closed 2023 with revenues from core management equal to…
Svas Biosana, double digit growth of half-yearly revenues
(Tiper Stock Exchange) – Svas Biosanaa primary operator in the healthcare sector, active in the production and distribution of medical devices for public and private healthcare facilities, recorded a sales…
Svas Biosana, Banca Profilo confirms Buy and target price at 17 euros
(Tiper Stock Exchange) – Bank Profile confirmed the “Buy” recommendation and the target price at 17 euros per share on the title Svas Biosana, a company listed on Euronext Growth…
Svas Biosana, 2022 profit rises to 3.6 million (+13%)
(Tiper Stock Exchange) – Svas Biosanaa company listed on Euronext Growth Milan and active in the production of medical devices for healthcare facilities, closed the 2022 with revenues equal to…
Svas Biosana buys treasury shares
(Tiper Stock Exchange) – Svas Biosana announced that, as part of the treasury share buyback program authorized by the Shareholders’ Meeting of 19 November 2021, from 13 to 17 March…
Svas Biosana, double digit increase in revenues
(Finance) – Svas Biosana registered a revenue consolidated as at 30 June 2022, not subject to statutory audit, which amounted to 43.8 million euros, up 13.6% compared to the same…
Svas Biosana, Board of Directors approves the 2021 budget
(Finance) – The Board of Directors of Svas Biosana examined and approved the consolidated financial statements and the draft financial statements at 31 December 2021 to be submitted to the…